Anti-HIV Natural Products from the plants Destributed in the Northern Part of Japan

来自日本北部植物的抗 HIV 天然产物

基本信息

  • 批准号:
    11694321
  • 负责人:
  • 金额:
    $ 1.73万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (B).
  • 财政年份:
    1999
  • 资助国家:
    日本
  • 起止时间:
    1999 至 2000
  • 项目状态:
    已结题

项目摘要

As a part of the structure-activity relationship study of the potent anti-HIV agent 3-Ο-(3', 3'-dimenthyl)-succinyl-betulinic acid(DSB), 3-Alkylamido-3-deoxy-betulinic acids were synthesized and evaluated for anti-HIV activity, 3-αDiglycorylamide-3-deoxy-betulinic acid demonstrated relatively potent anti-HIV activity(EC_<50> 0.24 μM, TI 728). However, replacing the ester group at C-3 in DSB and its analogues with an amido group yielded inactive or much less potent compounds against HIV replication, indicating that the ester group at C-3 in is essential for potent anti-HIV activity.Four isomers of 3,28-di-Ο-(dimethylsuccinyl)-betulin were prepared and evaluated for anti-HIV activity against HIV-1 replication in H9 lymphocyte cells. 3-Ο-(3', 3'-Dimethylsuccinyl)-28-Ο-(2", 2"-dimethylsuccinyl)-betulin was the most potent anti-HIV compound with an EC_<50> value of 0.00087 μM and a TI value of 42,400.3-Ο-Acyl-ursolic acids were prepared and evaluated their anti-HIV activities, based on our previous finding that 3-Ο-acyl-betulinic acid and -oleanolic acid, especially 3-Ο-(3', 3'-dimethyl)-succinyl-betulinic acid, and -oleanolic acid demonstrated potent anti-HIV activities(EC_<50> < 0.00035 and 0.00086 μM, respectively, therapeutic index(TI) > 20,000 and 22,326, respectively), as well as the fact that ursolic acid(6)showed similar level of anti-HIV activity(EC_<50> 4,4μM)to that of oleanolic acid(EC_<50> 3.7 μM), though it was slightly toxic(IC_<50> 14.3 μM, T.I.3.3). 3-Ο-Diglycoryl-ursolic acid demonstrated relatively potent anti-HIV activity with an EC_<50> 0.31 μM, and a TI of 155.5. In contrast, 3-Ο-(3', 3'-dimethylsuccinyl)-ursolic acid, corresponding to the extremely potent anti-HIV betulinic acid and oleanolic acid derivatives displayed only a weak anti-HIV activity(EC_<50> 2.1μM, T.I.23.6).
作为高效抗艾滋病药物3-Ο-(3‘,3’-二甲基)-琥珀酰白桦酸构效关系研究的一部分,合成了3-烷基酰胺-3-脱氧-白桦酸,并对其抗艾滋病活性进行了评价,3-α二甘油酰胺-3-脱氧-白桦酸表现出较强的抗艾滋病活性(EC_&lt;50&GT;0.24μM,TI728)。然而,用氨基取代DSB及其类似物中C-3位的酯基得到的化合物抗HIV-1复制活性较弱,表明C-3位的酯基团是有效抗HIV活性所必需的。制备了4种3,28-二Ο-(二甲基琥珀酰基)-桦木醇异构体,并评价了它们在H9淋巴细胞中抗HIV-1复制的活性。3-Ο-(3‘,3’-二甲基丁二酸基)-28-Ο-(2“,2”-二甲基丁二酸基)-桦木醇是最有效的抗艾滋病毒化合物,其EC50和GT;根据我们先前的研究发现,3-μ-(3‘,3’-二甲基)-琥珀酰白桦酸和-齐墩果酸,特别是3-Ο-(3‘,3’-二甲基)-琥珀酰白桦酸和-齐墩果酸表现出较强的抗艾滋病毒活性(EC_&lt;50&gt;&lt;0.00035和0.00086ΟM,治疗指数(TI)和GT;),并评价了它们的抗艾滋病毒活性(EC_&lt;50&gt;&lt;0.00035和0.00086Ο-M,治疗指数(TI)和GT;2,000和22,326),以及乌索酸(6)表现出与齐墩果酸(EC_&lt;50&gt;3.7μM)相似的抗艾滋病毒活性(EC_&lt;50&gt;4,4μM),尽管它有轻微的毒性(IC_&lt;50&gt;14.3μM,T.I.3.3)。3-Ο-二甘草酰-熊果酸具有较强的抗艾滋病毒活性,其EC50和TI值分别为0.31μM和155.5。相反,3-Ο-(3‘,3’-二甲基琥珀酰基)-熊果酸,对应于极强的抗艾滋病毒白桦酸和齐墩果酸衍生物,只显示出弱的抗艾滋病毒活性(EC_&lt;50&gt;2.1μM,T.I.23.6)。

项目成果

期刊论文数量(20)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Yoshiki Kashiwada: "Synthesis and Anti-HIV Activities of 3-Alkylamido-3-Deoxy-BetulinicAcid Derivatives"Chemical & Pharmaceutical Bulletin. 48・9. 1387-1390 (2000)
Yoshiki Kashiwada:“3-烷基酰胺-3-脱氧-桦木酸衍生物的合成和抗HIV活性”化学与制药通报48・9(2000)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Yoshiki Kashiwada: "3,28-Di-O-(Dimethylsuccinyl)-Betulin Isomers as Anti-HIV Agents"Bioorganic & Midicinal Chemistry Letters. 11・2. 183-185 (2001)
Yoshiki Kashiwada:“3,28-Di-O-(二甲基琥珀酰)-桦木醇异构体作为抗 HIV 药物”《生物有机与药物化学快报》11・2 (2001)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Yoshiki Kashiwada: "3, 28-Di-O-(Dimethylsuccinyl)-Betulin Isomers as Anti-HIV Agents"Bioorganic & Midicinal Chemistry Letters. 11・2. 183-185 (2001)
Yoshiki Kashiwada:“3, 28-Di-O-(二甲基琥珀酰)-桦木醇异构体作为抗 HIV 药物”《生物有机与药物化学快报》11・2 (2001)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Kashiwada, Y. ; Nagao, T. ; Hashimoto, A.. ; Ikeshiro, Y. ; Okabe, H. ; Cosentino, L.M. ; Lee, K.H.: "Anti-AIDS Agents 38. Anti-HIV Activities of 3-Ο-Acyl Ursolic Acid Derivatives"J.Nat.Prod.. 63(12). 1619-1622 (2000)
柏田,Y.;桥本,Y.;科森蒂诺,L.M.;李,K.H.:“3-Ο-的抗艾滋病毒活性”酰基熊果酸衍生物”J.Nat.Prod..63(12).1619-1622(2000)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KASHIWADA Yoshiki其他文献

KASHIWADA Yoshiki的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('KASHIWADA Yoshiki', 18)}}的其他基金

Development of anti-HIV agents with dual mechanisms of actions based on triterpenoids as drug discovery templates
以三萜类化合物为药物发现模板,开发具有双重作用机制的抗 HIV 药物
  • 批准号:
    15K07998
  • 财政年份:
    2015
  • 资助金额:
    $ 1.73万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Ethnobotanical research and effective utilization of Mongolian medicinal plants (secondary survey)
蒙古药用植物民族植物学研究及有效利用(二次调查)
  • 批准号:
    26305003
  • 财政年份:
    2014
  • 资助金额:
    $ 1.73万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Ethnobotanical research and effective utilization of Mongolian medicinal plants
蒙古药用植物的民族植物学研究与有效利用
  • 批准号:
    22406024
  • 财政年份:
    2010
  • 资助金额:
    $ 1.73万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Study on betulin and betulinic acid derivatives aimed at developing anti-HIV agents effective against resistant virus
研究桦木醇和桦木酸衍生物,旨在开发有效对抗耐药病毒的抗艾滋病毒药物
  • 批准号:
    22510233
  • 财政年份:
    2010
  • 资助金额:
    $ 1.73万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Colaborative Research on Anti-HIV Triterpenoids
抗HIV三萜类化合物的合作研究
  • 批准号:
    09044339
  • 财政年份:
    1997
  • 资助金额:
    $ 1.73万
  • 项目类别:
    Grant-in-Aid for international Scientific Research

相似海外基金

Optimization of Betulinic Acid analogs for T-type calcium channel inhibition for non-addictive relief of chronic pain
用于 T 型钙通道抑制的桦木酸类似物的优化,用于非成瘾性缓解慢性疼痛
  • 批准号:
    9907601
  • 财政年份:
    2019
  • 资助金额:
    $ 1.73万
  • 项目类别:
Study on betulin and betulinic acid derivatives aimed at developing anti-HIV agents effective against resistant virus
研究桦木醇和桦木酸衍生物,旨在开发有效对抗耐药病毒的抗艾滋病毒药物
  • 批准号:
    22510233
  • 财政年份:
    2010
  • 资助金额:
    $ 1.73万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Anti-stress activity of betulinic acid in rainbow trout (Oncorhyncus mykiss)
虹鳟鱼 (Oncorhyncus mykiss) 中桦木酸的抗应激活性
  • 批准号:
    361577-2009
  • 财政年份:
    2009
  • 资助金额:
    $ 1.73万
  • 项目类别:
    Postgraduate Scholarships - Master's
Anti-stress activity of betulinic acid in rainbow trout (Oncorhyncus mykiss)
虹鳟鱼 (Oncorhyncus mykiss) 中桦木酸的抗应激活性
  • 批准号:
    361577-2008
  • 财政年份:
    2008
  • 资助金额:
    $ 1.73万
  • 项目类别:
    Alexander Graham Bell Canada Graduate Scholarships - Master's
Betulinic acid derivatives as anti-HIV agents.
桦木酸衍生物作为抗 HIV 剂。
  • 批准号:
    7173456
  • 财政年份:
    2006
  • 资助金额:
    $ 1.73万
  • 项目类别:
Betulinic acid derivatives as anti-HIV agents.
桦木酸衍生物作为抗 HIV 剂。
  • 批准号:
    7340117
  • 财政年份:
    2006
  • 资助金额:
    $ 1.73万
  • 项目类别:
Betulinic acid derivatives as anti-HIV agents
桦木酸衍生物作为抗 HIV 药物
  • 批准号:
    8012352
  • 财政年份:
    2006
  • 资助金额:
    $ 1.73万
  • 项目类别:
Betulinic acid derivatives as anti-HIV agents
桦木酸衍生物作为抗 HIV 药物
  • 批准号:
    8260418
  • 财政年份:
    2006
  • 资助金额:
    $ 1.73万
  • 项目类别:
Betulinic acid derivatives as anti-HIV agents.
桦木酸衍生物作为抗 HIV 剂。
  • 批准号:
    7557845
  • 财政年份:
    2006
  • 资助金额:
    $ 1.73万
  • 项目类别:
Betulinic acid derivatives as anti-HIV agents
桦木酸衍生物作为抗 HIV 药物
  • 批准号:
    8636980
  • 财政年份:
    2006
  • 资助金额:
    $ 1.73万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了